Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Glenn P Muir is Director at Repligen. OQRO lists 7 transactions filed with the SEC under this name, the latest on May 29, 2026, each linked to the official Form 4.
Director
Disclosures on record
7
Companies involved
2
NeuroneticsSTIM
May 28, 202630Kdisclosed May 29
DetailsOfficial recordRepligenRGEN
6 disclosures · Dec 2025 – May 2026
May 14, 2026995disclosed May 19
May 14, 20262,239disclosed May 19
DetailsOfficial recordMay 7, 20262,434disclosed May 8
DetailsOfficial recordMay 7, 20262,434disclosed May 8
DetailsOfficial recordDec 16, 20253,366disclosed Dec 18
DetailsOfficial recordDec 16, 20253,366disclosed Dec 18
DetailsOfficial recordAs of the latest filing on , Glenn P Muir reported holding 40,051 shares of Repligen (RGEN), worth about $6.72M at the last close of $168 (Nov 13, 2026). Holdings are also on file at Neuronetics (STIM); together they are worth about $7.28M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Repligen RGEN | 40,051 | 40K direct | $168 | $6.72M | May 14, 2026 |
| Neuronetics STIM | 401,816 | 402K direct | $1 | $559K | May 28, 2026 |
Is this Glenn P Muir’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Glenn P Muir bought shares on the open market in 2018 and 2024, and has not bought since 2024.
Glenn P Muir reported 6 open-market purchases and 0 sales since 2018; purchases in 2 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2024 | $85K5×5 trades | — |
| 2018 | $680K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated May 14, 2026, Glenn P Muir reported holding 40,051 shares of Repligen (RGEN). At the last close of $168 on Nov 13, 2026, that is about $6.72M. This is the stake disclosed in filings, not a net worth.
Glenn P Muir bought shares on the open market in 2018 and 2024, and has not bought since 2024.
In SEC filings since 2018: the latest open-market purchase is from 2024; no open-market sale is on record.
Neuronetics (STIM), from 2018 to 2024: 6 purchases and 0 sales.
Glenn P Muir reported 6 open-market purchases and 0 sales here, 2018 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.